Holen Sie sich die Stockscreener-App
27.88
0.96%
0.25
Schlusskurs vom Vortag:
$27.63
Offen:
$27.91
24-Stunden-Volumen:
284.16K
Relative Volume:
0.24
Marktkapitalisierung:
$1.69B
Einnahmen:
$277.49M
Nettoeinkommen (Verlust:
$-192.14M
KGV:
-8.2976
EPS:
-3.36
Netto-Cashflow:
$-95.52M
1W Leistung:
+1.36%
1M Leistung:
-26.65%
6M Leistung:
-38.52%
1J Leistung:
-34.69%
1-Tages-Spanne:
$27.45
$28.20
1-Wochen-Bereich:
$24.28
$28.20
52-Wochen-Spanne:
$24.28
$55.33
Twist Bioscience Corp Stock (TWST) Company Profile
Firmenname
Twist Bioscience Corp
Sektor
Branche
Telefon
800-719-0671
Adresse
681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA
Vergleichen Sie TWST mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TWST
Twist Bioscience Corp
|
27.94 | 1.55B | 277.49M | -192.14M | -95.52M | -3.36 |
|
TMO
Thermo Fisher Scientific Inc
|
471.90 | 173.97B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
203.44 | 143.61B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
653.50 | 52.65B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
116.14 | 32.56B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
184.67 | 30.58B | 15.50B | 1.33B | 2.16B | 7.34 |
Twist Bioscience Corp Stock (TWST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2024-06-04 | Eingeleitet | Guggenheim | Buy |
| 2024-01-17 | Hochstufung | Goldman | Neutral → Buy |
| 2023-09-27 | Eingeleitet | Berenberg | Buy |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Outperform |
| 2023-01-03 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2022-03-02 | Fortgesetzt | Cowen | Outperform |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-06-29 | Eingeleitet | William Blair | Outperform |
| 2021-06-04 | Eingeleitet | Goldman | Neutral |
| 2021-04-12 | Eingeleitet | Piper Sandler | Overweight |
| 2021-02-05 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-01-04 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2020-10-20 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2019-05-31 | Eingeleitet | Evercore ISI | Outperform |
| 2018-11-26 | Eingeleitet | JP Morgan | Neutral |
Alle ansehen
Twist Bioscience Corp Aktie (TWST) Neueste Nachrichten
Improving Crop Resilience with AI and DNA Synthesis - the-scientist.com
After Plunging 33.8% in 4 Weeks, Here's Why the Trend Might Reverse for Twist Bioscience (TWST) - Nasdaq
Twist Bioscience’s DNA Ambitions Face Growth And Profit Hurdles - Finimize
Finn, Twist Bioscience COO, sells $90k in shares By Investing.com - Investing.com Nigeria
Cho Dennis, SVP at Twist Bioscience, sells $22k in shares - Investing.com Nigeria
Cho Dennis, SVP at Twist Bioscience, sells $22k in shares By Investing.com - Investing.com South Africa
Leproust, Twist Bioscience CEO, sells $158k in stock By Investing.com - Investing.com Canada
Finn, Twist Bioscience COO, sells $90k in shares - Investing.com India
Green Paula, SVP at Twist Bioscience, sells $35k in shares - Investing.com
Werner, Twist Bioscience CAO, sells $5275 in TWST stock - Investing.com
Twist Bioscience Executives Sell Shares to Cover Tax Obligations - TradingView
Twist Bioscience Corporation (NASDAQ:TWST) Q3 2025 Earnings Call Transcript - Insider Monkey
Twist Bioscience stock hits 52-week low at 27.12 USD By Investing.com - Investing.com South Africa
Twist Bioscience stock hits 52-week low at 27.12 USD - Investing.com India
Twist Bioscience appoints Trynka Shineman Blake to board of directors - Investing.com
Twist Bioscience Appoints Trynka Shineman Blake to Board of Directors - Business Wire
A Quick Look at Today's Ratings for Twist Bioscience(TWST.US), With a Forecast Between $25 to $46 - 富途牛牛
JPMorgan lowers Twist Bioscience stock price target to $25 from $33 - Investing.com
Twist Bioscience Corp (TWST) Q3 2025 Earnings Call Highlights: Record Revenue and Strategic ... - Yahoo Finance
Can Traders Expect Breakout From Twist Bioscience Corporation This WeekEntry Zone Strategy for Consistent Profit Shared - metal.it
Twist Bioscience Corp SEC 10-Q Report - TradingView
Twist Bioscience Turns The Tide: Q3 Sales Jump, Beats Earnings - Benzinga
Twist Bioscience earnings beat by $0.86, revenue topped estimates - Investing.com
Twist Bioscience stock price target lowered to $36 by TD Cowen - Investing.com South Africa
Twist Bioscience: Fiscal Q3 Earnings Snapshot - The Washington Post
Evercore ISI lowers Twist Bioscience stock price target on revenue timing - Investing.com
Evercore ISI lowers Twist Bioscience stock price target on revenue timing By Investing.com - Investing.com South Africa
Twist Bioscience (TWST) Shares Drop 16.4% on Market Movements - GuruFocus
Earnings call transcript: Twist Bioscience Q3 2025 sees revenue rise 18% By Investing.com - Investing.com South Africa
Earnings call transcript: Twist Bioscience Q3 2025 sees revenue rise 18% - Investing.com Nigeria
Twist Bioscience (TWST) Q3 Profit Surges - The Motley Fool
Twist Bioscience (TWST) Q3 Profit Surges - Nasdaq
Twist Bioscience Announces Fiscal 2025 Third Quarter Financial Results - TradingView
Twist Bioscience (TWST) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Twist Bioscience Q3 2025 slides: revenue hits $96.1M as margins exceed 50% target - Investing.com Canada
Will a bounce in Twist Bioscience Corporation offer an exitFree Real Time Alerts Based on AI Prediction - Newser
Using portfolio simulators with Twist Bioscience Corporation includedFree Stock Market Entry Timing Signals - Newser
Will Twist Bioscience Corporation benefit from macro trendsPredictive Model for Intraday Swing Forecast - Newser
What risks could impact Twist Bioscience Corporation stock performanceShort Squeeze Opportunities with Indicators - Newser
What catalysts could drive Twist Bioscience Corporation stock higher in 2025Maximize returns with data-driven strategies - Jammu Links News
Using Bollinger Bands to evaluate Twist Bioscience CorporationNeural Network Based Equity Prediction System - Newser
Twist Bioscience Corporation stock momentum explainedFree ROI Driven Equity Selection With Safety - Newser
What makes Twist Bioscience Corporation stock price move sharplyFinancial News Report For Fast Growth - Jammu Links News
Stocks in play: First Mining Gold Corp - The Globe and Mail
Twist Bioscience launches humanized transgenic mouse model By Investing.com - Investing.com Canada
Twist Bioscience launches humanized transgenic mouse model - Investing.com
Twist Bioscience Expands In Vivo Antibody Discovery Services with Launch of Humanized Transgenic Mouse Model - Business Wire
What MACD and RSI say about Twist Bioscience CorporationExpert-Backed High Yield Stock Watchlist - Newser
Why Twist Bioscience Corporation stock attracts strong analyst attentionAsset Allocation Summary With Future Outlook - Newser
Using fundamentals and technicals on Twist Bioscience CorporationLong Term Stock Planner with Safety Checks - Newser
Is There An Opportunity With Twist Bioscience Corporation's (NASDAQ:TWST) 27% Undervaluation? - Yahoo Finance
Finanzdaten der Twist Bioscience Corp-Aktie (TWST)
Umsatz
Nettogewinn
Free Cashflow
ENV
Twist Bioscience Corp-Aktie (TWST) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Leproust Emily M. | Chief Executive Officer |
Aug 04 '25 |
Sale |
28.36 |
5,585 |
158,413 |
639,721 |
| Green Paula | SVP of Human Resources |
Aug 04 '25 |
Sale |
28.36 |
1,255 |
35,597 |
126,206 |
| Cho Dennis | See Remarks |
Aug 04 '25 |
Sale |
28.36 |
785 |
22,266 |
103,827 |
| Finn Patrick John | President and COO |
Aug 04 '25 |
Sale |
28.36 |
3,189 |
90,453 |
235,153 |
1.37%
0.60%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):